Becton, Dickinson and Company BDX
183.82
4.59
2.56%
as of 25 Sep
- Market cap
- $48.8B
- P/E
- 55.4×
Follow BDX
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Becton, Dickinson and Company (BDX) P/B ratio
As of 25 September 2026, Becton, Dickinson and Company (BDX) trades at a P/B ratio of 2.1×. Over the past ten years it has ranged from 1.5× (May 2025) to 4.4× (March 2015); the current reading is higher than 21% of that period. That is below the Medical Instruments & Supplies industry median of 2.8× and below the Healthcare sector median of 2.5×.
P/B ratio, daily
Annual
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 1.7× | (21.42%) |
| FY2024 | 2.1× | (5.67%) |
| FY2023 | 2.2× | 13.86% |
| FY2022 | 2.0× | (14.27%) |
| FY2021 | 2.3× | 9.96% |
| FY2020 | 2.1× | (15.68%) |
| FY2019 | 2.5× | (0.44%) |
| FY2018 | 2.5× | (1.98%) |
| FY2017 | 2.5× | (33.71%) |
| FY2016 | 3.8× | 33.54% |
Quarterly
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 1.7× | (6.86%) |
| Mar 2026 | 1.8× | 6.10% |
| Dec 2025 | 1.7× | 3.38% |
| Sep 2025 | 1.7× | 9.20% |
| 42 more quarters | Free account |
Against its own ten years
Low 1.5×
High 4.4×
Ten-year median
2.3×
Current reading's percentile
21
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| ALC Alcon compare | 1.5× |
| MDLN Medline Inc. compare | 1.6× |
| BAX Baxter International Inc. compare | 2.0× |
| BDX Becton, Dickinson and Company | 2.1× |
| SOLV Solventum Corporation compare | 3.2× |
| RMD ResMed Inc. compare | 4.9× |
| RGEN Repligen Corporation compare | 5.1× |
| ISRG Intuitive Surgical, Inc. compare | 7.8× |
| WST West Pharmaceutical Services, Inc. compare | 8.8× |
| Medical Instruments & Supplies industry median | 2.8× |
| Healthcare sector median | 2.5× |
| Market median | 1.8× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on BDX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement